LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
LENSAR, Inc.NASDAQ: LNSR
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $1.13M rose 5.3% year over year, behind the +11.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 3.5% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Depreciation & amortization amounted to 7.7% of revenue in FY2025, up 0.4 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +5.3% toward the trailing-twelve-month pace of +11.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 4.5M USD
- Year-over-year change
- +14.5%
- 4-year CAGR
- +13.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.5M | +14.5% |
| FY2024 | 2024-12-31 | 3.93M | +11.8% |
| FY2023 | 2023-12-31 | 3.52M | +3.2% |
| FY2022 | 2022-12-31 | 3.41M | +23.2% |
| FY2021 | 2021-12-31 | 2.76M | — |
Depreciation & Amortization vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 depreciation & amortization of $4.56M is the 3rd largest of the 10 companies compared; the peer median is $1.17M.
- Its year-over-year change of +11.6% is the 2nd highest of 10, against a peer median of -20.5%.
- Depreciation & amortization amounts to 7.9% of revenue for LNSR, versus a peer median of 6.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $5.54M | -27.5% | -26.6% | 4.8% | |
| LTM Mar 2026 | $4.68M | +4.5% | +24.0% | 14.5% | |
| LTM Mar 2026 | $4.56M | +11.6% | +9.7% | 7.9% | |
| LTM Mar 2026 | $3.11M | -8.6% | +4.7% | 9.0% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $1.69M | +7.8% | +29.0% | 91.1% |
| LTM Mar 2026 | $1.17M | +120.2% | +56.5% | 222.3% | |
| LTM Mar 2026 | $627K | -41.1% | -39.6% | 0.6% | |
| LTM Mar 2026 | $589K | -20.5% | +16.3% | 1.3% | |
| LTM Mar 2026 | $499.37K | -27.3% | -29.2% | 2.6% | |
| LTM Mar 2026 | $287K | -146.9% | — | — | |
| Peer median (excluding LNSR) | $1.17M | -20.5% | +10.5% | 6.9% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.